Geneos Wealth Management’s WisdomTree U.S. Short Term Corporate Bond Fund QSIG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-777
Closed -$37K 2633
2022
Q2
$37K Hold
777
﹤0.01% 1411
2022
Q1
$37K Buy
+777
New +$38.5K ﹤0.01% 1512
2020
Q4
Sell
-65
Closed -$3K 3020
2020
Q3
$3K Hold
65
﹤0.01% 2354
2020
Q2
$3K Sell
65
-147
-69% -$7.52K ﹤0.01% 2315
2020
Q1
$10K Buy
212
+132
+165% +$6.66K ﹤0.01% 1837
2019
Q4
$4K Buy
+80
New +$4.06K ﹤0.01% 2269

Other funds holding QSIG

Geneos Wealth Management's QSIG Position: Q3 2022 in Review

Geneos Wealth Management sold out of WisdomTree U.S. Short Term Corporate Bond Fund (QSIG) in Q3 2022, closing a stake of 777 shares — an estimated $37K sold.

Geneos Wealth Management first reported a position in QSIG in Q4 2019 and held it in 6 quarters. The position peaked at $37K in Q2 2022. 15 funds tracked by Wall St. Rank hold QSIG as of Q3 2022.

  • Geneos Wealth Management reported no remaining WisdomTree U.S. Short Term Corporate Bond Fund position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 777 WisdomTree U.S. Short Term Corporate Bond Fund shares in Q3 2022, an estimated $37K.
  • Geneos Wealth Management first reported a position in WisdomTree U.S. Short Term Corporate Bond Fund in Q4 2019 and held it in 6 quarters.
  • Geneos Wealth Management's WisdomTree U.S. Short Term Corporate Bond Fund position peaked at $37K in Q2 2022.
  • 15 funds tracked by Wall St. Rank held WisdomTree U.S. Short Term Corporate Bond Fund as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.